Patent Yard Sign in
Expired Canadian patentCanada

Stable oxapenem-3-carboxylic acids

CA 1339450 C · Owner: Bayer Aktiengesellschaft · Inventors: Hendel, Wolfram; Pfaendler, Hans Rudolf

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of the structural formulae, (see fig.I) or (see fig.II) and their pharmaceutically acceptable salts esters and, amide derivatives, in which R1 and R2 independently of, one another, denote hydrogen or pharmaceutically acceptable groups which have 1 to 10 carbon atoms and are bonded to the remaining part of the molecule via carbon-carbon single bonds, and in which R3, R4 and R5 independently, of one another, denote pharmaceutically acceptable groups which have 1 to 10 carbon atoms and are bonded to the remaining part of the molecule via carbon-carbon single bonds, are useful antibiotics. The trisubstitution by three groups R3 R4 and, R5, which are bonded via carbon-carbon single …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted September 9, 1997. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended September 9, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 29, 1988
GrantedSeptember 9, 1997
Term endedSeptember 9, 2014
Patent numberCA 1339450 C
Classification (IPC)C07D503/10 +2 more

Timeline

Timeline From CIPO dates

198919921995199820012004200720102013Application filedJuly 29, 1988Patent grantedSep 9, 1997Term endedSep 9, 2014

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.